We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
(+4.7%)
Cap. Flow
+$1.58M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$7.05M |
| 2 |
Amazon
AMZN
|
+$3.89M |
| 3 |
uniQure
QURE
|
+$2.86M |
| 4 |
BioNTech
BNTX
|
+$2.81M |
| 5 |
DexCom
DXCM
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.6M |
| 2 |
Procter & Gamble
PG
|
+$3.27M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.16M |
| 4 |
CVS Health
CVS
|
+$3.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.23% |
| 2 | Healthcare | 25.2% |
| 3 | Consumer Discretionary | 20.47% |
| 4 | Communication Services | 8.05% |
| 5 | Financials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
NovoCure
NVCR
$2.05B
| $78.2K | 0.03% |
1,066
+85
| +9% | +$6.4K |
|
127
Carnival Corporation Ltd
CCL
$37.9B
| $77.2K | 0.03% |
9,580
-14,500
| -60% | -$125K |
|
128
Amphenol
APH
$210B
| $76.3K | 0.03% |
+2,000
| New | +$75.7K |
|
129
Ascendis Pharma A/S
ASND
$16.8B
| $69.2K | 0.03% |
567
+47
| +9% | +$5.46K |
|
|
KRTX
130
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $68.6K | 0.03% |
349
+31
| +10% | +$6.65K |
|
131
Medpace
MEDP
$16.7B
| $67.1K | 0.03% |
316
+26
| +9% | +$5.19K |
|
132
Guardant Health
GH
$22.2B
| $66.3K | 0.03% |
2,436
+84
| +4% | +$3.84K |
|
133
Roivant Sciences
ROIV
$26.1B
| $58.9K | 0.02% |
+7,369
| New | +$41K |
|
|
APLS
134
DELISTED
Apellis Pharmaceuticals
APLS
| $58.1K | 0.02% |
1,123
+94
| +9% | +$4.99K |
|
135
Ionis Pharmaceuticals
IONS
$9.39B
| $54.5K | 0.02% |
1,443
+114
| +9% | +$4.79K |
|
136
Exelixis
EXEL
$12.5B
| $52.6K | 0.02% |
3,277
+263
| +9% | +$4.29K |
|
|
ITCI
137
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $50.9K | 0.02% |
962
+78
| +9% | +$3.91K |
|
138
Madrigal Pharmaceuticals
MDGL
$12.4B
| $50.5K | 0.02% |
174
-2,424
| -93% | -$237K |
|
|
RXDX
139
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $46.9K | 0.02% |
426
+43
| +11% | +$2.79K |
|
140
Cytokinetics
CYTK
$10.5B
| $44K | 0.02% |
961
-27,087
| -97% | -$1.17M |
|
141
Arrowhead Research
ARWR
$12.3B
| $43.7K | 0.02% |
1,077
+85
| +9% | +$2.82K |
|
142
Alkermes
ALKS
$8.44B
| $43.6K | 0.02% |
1,669
+131
| +9% | +$3.13K |
|
143
ZTO Express
ZTO
$17.6B
| $43K | 0.02% |
+1,600
| New | +$36.8K |
|
144
Vaxcyte
PCVX
$8.88B
| $38.5K | 0.02% |
803
+248
| +45% | +$9.73K |
|
145
Denali Therapeutics
DNLI
$4.04B
| $38.4K | 0.02% |
1,380
+225
| +19% | +$6.7K |
|
|
SYNH
146
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $38.3K | 0.02% |
1,045
+84
| +9% | +$3.32K |
|
147
Beam Therapeutics
BEAM
$2.76B
| $37.2K | 0.02% |
952
+57
| +6% | +$2.55K |
|
|
FOLD
148
DELISTED
Amicus Therapeutics
FOLD
| $34.8K | 0.01% |
2,854
+227
| +9% | +$2.56K |
|
149
Vir Biotechnology
VIR
$1.52B
| $34.2K | 0.01% |
1,353
+111
| +9% | +$2.72K |
|
150
Axsome Therapeutics
AXSM
$11.2B
| $34K | 0.01% |
441
+64
| +17% | +$3.83K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2022 Portfolio in Review
As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
- China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
- China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
- China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
- China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
- China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
- China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.
Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.